(The Center Square) – Local governments’ share of opioid settlement funds in North Carolina is at about $1.3 billion following Monday’s settlement announcement between Pennsylvania pharmaceutical company Mylan and 15 states.
Mylan, a part of Viatris through merger with Pfizer’s Upjohn business just over four years ago, was not required to admit wrongdoing as part of the agreement, published reports say. The payout of as much as $9 million to North Carolina and $335 million to all the states involved in the litigation will be in a nine-year period.
Tracking back to the days of previous attorneys general, North Carolina has won an estimated $1.6 billion in opioid settlement funds. How local governments use their share is tracked at CORE-NC, an acronym and portal for the Community Opioid Resources Engine.
Mylan produces generic fentanyl patches, oxycodone, hydrocodone and buprenorphine products, a release from North Carolina Attorney General Jeff Jackson said. He said the company knew how addictive the products were and “misled the American people for years, worsening the opioid crisis, fueling the fentanyl crisis, and killing North Carolinians.”
Gov. Josh Stein was the Democratic attorney general for eight years prior to Jackson when the suit began.
